ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

TSTL Tristel Plc

465.00
0.00 (0.00%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Tristel Plc LSE:TSTL London Ordinary Share GB00B07RVT99 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 465.00 460.00 490.00 - 0.00 07:43:19
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Med, Dental, Hosp Eq-whsl 36.01M 4.46M 0.0941 49.42 220.41M
Tristel Plc is listed in the Med, Dental, Hosp Eq-whsl sector of the London Stock Exchange with ticker TSTL. The last closing price for Tristel was 465p. Over the last year, Tristel shares have traded in a share price range of 327.50p to 499.00p.

Tristel currently has 47,400,993 shares in issue. The market capitalisation of Tristel is £220.41 million. Tristel has a price to earnings ratio (PE ratio) of 49.42.

Tristel Share Discussion Threads

Showing 3651 to 3672 of 4000 messages
Chat Pages: Latest  148  147  146  145  144  143  142  141  140  139  138  137  Older
DateSubjectAuthorDiscuss
26/4/2021
21:40
STD it's a call center which Will be taken over by AI technologyAnd you have a gang of pump and dumpers working the TLY message board
football
26/4/2021
20:57
From the TU:

Elective ops is the area where TLY is a specialists and, with their insourcing division, are helping the NHS reduce the high waiting list.
TLY's insourcing division is growing strongly as can be seen from their recent TU.


"The departments and types of treatment that we focus upon are experiencing many of the longest NHS waiting times. NHS sources quoted recently in the Press(1) state the total numbers of people waiting for examinations in ENT is circa 366,000; ophthalmology 494,000; urology 270,000; cardiology 194,000, and gynaecology 265,000. These departments account for most of our medical device disinfectant product sales, and they also represent the highest patient waiting numbers in UK hospitals outside of orthopaedics, trauma, and general surgery. We understand that the NHS is making available a GBP1.5bn(2) Elective Recovery Fund to accelerate the restoration of services and treatment for as many people as possible."

sikhthetech
26/4/2021
18:40
Tristel plc("Tristel" or the "Company")Director/PDMR ShareholdingTristel plc (AIM: TSTL), the manufacturer of infection prevention, contamination control and hygiene products, announces that on 26 April 2021, Paul Swinney, Chief Executive Officer, purchased 8,104 ordinary shares of 1 penny each in the Company ("Ordinary Shares") at a price of 572.75 pence per share.As a result, Mr. Swinney's beneficial interest in the Company is 700,000 Ordinary Shares, representing 1.49 per cent. of the total issued share capital.
leopoldalcox
26/4/2021
11:34
Look the worked buys that went try at 11.00. 145K, 50k, 96K.

MMS was ticking bid side with small sells while filling the orders.

I suspect the buyerss now will start buying the open market to push it back to 600p

virtues and strengths
26/4/2021
10:27
FWIW,
finnCap research target price of 550p

Link to register:

Thanks to Lianne at Walbrook

piedro
26/4/2021
09:14
If you historically analyse price action versus valuation across many years and markets it has been shown many times that current valuation is a very poor indicator of where price is going.
davr0s
26/4/2021
09:12
Valuation.....very high rating possibly justified by past performance but no longer following today's TU.....IMO

May be tempted to get back in at £5.......

jaf111
26/4/2021
09:04
It's trading in a perfectly normal range still and despite some short term weakness the outlook seems fine. No doubt we get a string of people plucking lower number targets out of thin air and with weak hands will run for the exits as its always the way.Don't get me wrong I have an exit point where I'd conclude I'm wrong but it's nowhere close to the current price
davr0s
26/4/2021
08:51
surely this should fall further???
jaf111
26/4/2021
08:15
A return to pre-covid prices or worse could be on the cards here. Large scale benefits from surface cleaning haven't happened and device cleaning has been impacted by almost complete shutdown of non covid hospital visits. I might buy back on a return to last year's prices although the company's generous issue of options is still an issue for me.
melton john
26/4/2021
07:56
NHS
Classification: Official
Publications approval reference: PAR468
2021/22 priorities and operational planning guidance
25 March 2021

piedro
26/4/2021
07:50
That is what is known as a PROFIT WARNING

IMHO

- we have had them before .... .... and survived!

GLA.

piedro
26/4/2021
07:18
Trading update out - turnover unchanged. UK market struggling due to cover delays. Focus towards US. Outlook seems positive, subject to cover.
paulisi
25/4/2021
11:50
I thought I would post the recent TU from Byotrol and link to an outstanding interview that aired late Friday.

Already a Tristel partner but on a rating of about 1/3 of Tristel, so happy to buy lots there and keep my holding here.

Sanitiser specialist Byotrol 'have had an extraordinary year' says CEO David Traynor

23 Apr 2021



"We've had an extraordinary year, are pleased with the performance so far and are very excited about what's to happen in the future for us" said David Traynor.

"Turnover has pretty much doubled in 12 months to over £11 million, and EBITDA was up by 6.5 times [to £1.7M], that's a pretty good performance by any measure. And we have no debt, we paid off all our debt over the year, financially we are very very strong and we are looking for growth going forwards" explained David.

Next year: "I would expect to put out more information on product launches across B2B and B2C, I would expect to be announcing more licences and alliances as we have done before, with more focus on three areas:
1. new products and ingredients for the professional market, sometimes to create a gap in their portfolio which we spot for them
2. More direct to consumer work - we did 20% of our work direct to retailers and retailers as partners, and I think we can do better than that
3 Third area is licences and alliances across those two areas."


#Byotrol​ #BYOT​ #sanitiser​ #anti​-viral #Covid​-19 #AIM​ #Recordturnover̴3; #Tradingupdate​; #David​ Traynor #Turtlewax​ #Soltech​ #Byoworks​ #NHS​ #Tristal



WATCH INTERVEIW BELOW







12.01 £1mil to come in payments 14.00 seaweed stuff looks very good

new today

loafofbread
22/4/2021
12:49
Price ticking upwards - still no news on N American approval...
paulisi
19/4/2021
11:40
RNS Number : 1028H
Tristel PLC
23 March 2020

Know-How License and Product Supply Agreement with Byotrol plc ("Byotrol")
Tristel plc (AIM: TSTL), the manufacturer of infection prevention and contamination control products announces that it has entered into a know-how licence and commercial collaboration with Byotrol ....
.... ....
Jointly developed formulation
The formulation combines Tristel's chlorine dioxide chemistry, which is sporicidal meaning that it has the highest level of disinfection efficacy, with ACTIZONE, a Solvay S.A. technology developed in collaboration with Byotrol and which enables a disinfectant to have long-lasting efficacy on a surface for an 8-hour period after first application. Tristel will incorporate the jointly developed formulation in several packaging formats under the family name "Tristel8". These products will be unique worldwide in combining sporicidal efficacy with residual disinfection efficacy.

- no mention of a "Tristel24"

piedro
19/4/2021
11:16
MEDIMARK SCIENTIFIC - Animal Health@ANIGENEHLD4V
Provide your staff and clients with #24Hour protection from
#Coronavirus with @byotrol 4 in 1 Multipurpose Cleaner Disinfectant.
Proven to give residual protection against #EnvelopedViruses
in real-life conditions



- When will Tristel be launching its own long action disinfectant?
- but with only 8 hour protection

piedro
17/4/2021
10:25
Nice to see some advertising ...



Tristel in the Clinical Services Journal newsletter

piedro
13/4/2021
23:03
disappointing share price action - have I missed an analyst report or something similar?
melody9999
11/4/2021
21:42
Thanks Piedro for the background research. Looks a fairly decent collaboration which isn't priced in yet to the share price I would only be worried if there was a runaway metro train or a collapsing building which would detract Parker Laboratory from focusing on the job in hand. If I am totally honest as an investor the fact that he has ignored wealth and fame and looks to action as a reward is a poor outlook but could be raised at the AGM.

I note for balance as investors have often been critical of Paul Swinney and his remuneration he did in fairness take a hit of £60.18 when he Bed and Isa'd his shares in the open market last week.

mach100
09/4/2021
23:45
Mach100, I looked it up ...

Spiderman Theme Lyrics

Spider-Man, Spider-Man,
Does whatever a spider can
Spins a web, any size,
Catches thieves just like flies
Look Out!
Here comes the Spider-Man.

Is he strong?
Listen bud,
He's got radioactive blood.
Can he swing from a thread?
Take a look overhead
Hey, there
There goes the Spider-Man.

In the chill of night
At the scene of a crime
Like a streak of light
He arrives just in time.

Spider-Man, Spider-Man
Friendly neighborhood Spider-Man
Wealth and fame
He's ignored
Action is his reward.

To him, life is a great big bang up
Wherever there's a hang up
You'll find the Spider-Man.

[Thanks to bhavyabpopat7777 for correcting these lyrics]
Copyright: Lyrics © Original Writer and Publisher
source: hxxps://www.lyricsondemand.com/tvthemes/spidermanlyrics.html

piedro
09/4/2021
21:32
Nice jump...
paulisi
Chat Pages: Latest  148  147  146  145  144  143  142  141  140  139  138  137  Older

Your Recent History

Delayed Upgrade Clock